Press release
Prostate Cancer Therapeutics Market Study, Competitive Strategies, Forecast 2025: Teva Pharmaceuticals, Sanofi, Pfizer, Johnson & Johnson, Bristol-Myers Squibb, Astellas Pharma, Bayer, AstraZeneca, Dendreon, AbbVie
Global Prostate Cancer Therapeutics Market
Global Prostate Cancer Therapeutics Market, By Drug Type (Hormonal Therapy, Luteinizing Hormone-Releasing Hormone (LHRH) Agonist, Anti-Androgens, Immunotherapy, Targeted Therapy, Chemotherapy), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)– Industry Trends and Forecast to 2025
To request a sample copy or view summary of this report, click the link below: https://databridgemarketresearch.com/request-a-sample/?dbmr=global-prostate-cancer-therapeutics-market
Increase in research & development in oncology therapeutic area to drive the global prostate cancer therapeutics market is estimated to grow in the forecast period of 2018 to 2025 with the CAGR of 12.5%.
Major Market Competitors/Players: Global Prostate Cancer Therapeutics Market
Some of the major players operating in the global prostate cancer therapeutics market are Tolmar INC, Ferring Pharmaceuticals, Takeda pharmaceutical co. Ltd., Teva Pharmaceutical Industries LTD, Sanofi-Aventis, Pfizer Inc, Johnson & Johnson, IPSEN, Endo Pharmaceuticals Inc (Indevus Pharmaceuticals Inc) , Dendreon Corporation, Bristol-Myers Squibb, Astellas Pharma Inc, Astrazeneca Plc, Active Biotech, Abbott Laboratories, Bayer AG, Dendreon Corporation (Sanpower Group Co. Ltd.), AbbVie, Inc. among others.
Competitive Analysis:
The global prostate cancer therapeutics market is
highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of prostate cancer therapeutics market for global, Europe, North America, Asia Pacific and South America.
Major Topics Covered:
1. Introduction
2. Market Segmentation
3. Executive Summary
4. Market Overview
5. Premium Insights
6. Global Prostate Cancer Therapeutics Market: Regulatory Scenario
7. Global Prostate Cancer Therapeutics Market, By Drug Type
8. Global Prostate Cancer Therapeutics Market, By Distribution Channel
9. Global Prostate Cancer Therapeutics Market, By End User
10. Global Prostate Cancer Therapeutics, By Geography
11. Global Prostate Cancer Therapeutics, Company Landscape
12. Company Profiles
13. Related Reports
Any Questions? Inquiry before Buying Visit @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-prostate-cancer-therapeutics-market
Key questions answered in this report
1. What will be the market size in 2025 and what will
the growth rate?
2. What are the key market trends?
3. What is driving this market?
4. What are the challenges to market growth?
5. Who are the key vendors in this market space?
Key Developments in the Market:
In May 2018, Ferring Pharmaceuticals has done an agreement giving the company the option to secure global commercialisation rights to nadofaragene firadenovec/Syn3 (rAd-IFN/Syn3), a novel gene therapy that is being developed by FKD Therapies Oy (FKD) as a treatment for patients with high-grade non-muscle invasive bladder cancer (NMIBC), who are unresponsive to Bacillus Calmette-Guérin (BCG) therapy. This option is exercisable on marketing approval from the US FDA. This will create a new US oncology division with the specialist knowledge and presence to introduce novel advanced therapies to the market.
Major Market Drivers and Restraints:
• Innovative drugs driving the market
• Increase in research & development in
oncology therapeutic area
• Developments in genomics & proteomics
• Adverse events of treatment
• Cost associated with the treatment
• Low success rate in clinical testing for oncology
drugs
Click Here for Table of Content to Better
Understanding of Report @ https://databridgemarketresearch.com/toc/?dbmr=global-prostate-cancer-therapeutics-market
Report Overview:
On the basis of drug type, the market is classified into
• hormonal therapy,
• luteinizing hormone-releasing hormone (LHRH) agonist,
• anti-androgens,
• immunotherapy,
• targeted therapy,
• chemotherapy
On the basis of distribution channel
• hospital pharmacies,
• retail pharmacies,
• online pharmacies
Based on geography
• North America & South America,
• Europe,
• Asia-Pacific
• Middle East & Africa
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Prostate Cancer Therapeutics Market Study, Competitive Strategies, Forecast 2025: Teva Pharmaceuticals, Sanofi, Pfizer, Johnson & Johnson, Bristol-Myers Squibb, Astellas Pharma, Bayer, AstraZeneca, Dendreon, AbbVie here
News-ID: 1780650 • Views: …
More Releases from Data Bridge Market Research
Vitamin K Market IS growing at a CAGR of 6.8% during the forecast period of 2023 …
Vitamin K Market Analysis and Size
The essential factors contributing to the growth of the market in the forecast period of 2023 to 2020 include growing demand for vitamin supplements, changing dietary patterns, and rising health consciousness.
Data Bridge Market Research analyses that the global vitamin K market, which was USD 841.47 million in 2022, is expected to reach USD 1,410.20 million by 2030, growing at a CAGR of 6.8% during the…
Transformer Oil Market is expected to undergo a CAGR of 7.55% by 2029
Transformer Oil Market Analysis and Size
Transformers are almost everywhere, and every power and distribution transformer is filled with the dielectric insulating fluid, which consists high resistance to electricity and cools the transformer. The "bio based oil" is the highest growing type segment because it has better resistance to fire as compared to other oil over the forecast period. Furthermore, the growth of electric grids in developing economies and the upgradation…
Fatty Alcohols Market is expected to undergo a CAGR of 5.15% by 2029
Fatty Alcohols Market Analysis and Size
The rising demand of hygiene product coupled with growing consumer awareness is anticipated to drive the personal care industry and boost the growth of the fatty alcohols market. Fatty alcohols are used as emollients, emulsifiers and catalytic hydrogenation in cosmetics and beauty products. The "C11-C14 fatty alcohols" is the fastest growing product segment because it is used to produce sodium laureth ether sulphate (SLES), a major foaming agent…
Exclusive Insights on Gusseted Bags Market Latest Trends, Drivers, Strategies an …
An important Gusseted Bags Market research report is produced by taking into account every requirement that organizations need to meet in order to expand successfully. This market report forecasts the market size based on data on major retailer sales, industry growth by upstream and downstream factors, industry advancement, major players, market segments, and application. When creating the reliable Gusseted Bags Market study, the goals of the marketing research are taken into…
More Releases for Prostate
Prostate 911 Reviews 2021: ( Unrevealed truth) Prostate 911 100% Risk free SCAM …
Benign prostatic hyperplasia is a frequent condition that most guys have to deal with as they get older. Your prostate gland will grow to the measurement of a lemon. It will block the bladder, which will disrupt urine flow. It will motive damage to the urinary tract. It will purpose erectile dysfunction, bladder infection, and kidney problems. More than 50% of men go through from BPH between the age of…
Global Prostate Cancer Therapeutics Market
Global Prostate Cancer Therapeutics Market – Industry Analysis and Forecast (2018-2026) –By Product Type, End User, and Region.
Global Prostate Cancer Therapeutics Market was valued at US$ 9.21 Bn in 2017 and is expected to reach US$ 16.21 Bn by 2026, at a CAGR of 7.33 % during a forecast period.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data,…
Prostate Cancer Therapeutics Market: Future Perspective Growth In Prostate Cance …
Global Prostate Cancer Therapeutics Market
Precision Business Insights (PBI) in its report titled “Global Prostate Cancer Therapeutics Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.
Prostate Cancer Therapeutics Market
Prostate is an exocrine…
Prostate Biopsy Forceps Market
Global Prostate Biopsy Forceps Market Status and Trend Report offers a comprehensive analysis on Prostate Biopsy Forceps industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information.
Browse Full Report with TOC: http://orbisresearch.com/contacts/request-sample/2072536
Key questions answered by this report include:
Worldwide and Regional Market Size of Prostate Biopsy Forceps 2013-2017,…
Prostate Cancer - Pipeline Review, H1 2017
Report Hive Market Research Released a New Research Report of 1845 pages on Title " Prostate Cancer - Pipeline Review, H1 2017 "with detailed Analysis, Forecast and Strategies.
Prostate Cancer - Pipeline Review, H1 2017
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer - Pipeline Review, H1 2017, provides an overview of the Prostate Cancer (Oncology) pipeline landscape.
Prostate cancer is a form of cancer that affects men and…
US Prostate Cancer Drug Pipeline Analysis
Prostate cancer has emerged as one of the most commonly diagnosed cancer among men in the US. According to the American Cancer Society, there were close to 242,000 new cases of prostate cancer in the US in 2012, with 28,000 men dying from it. This was an increase from 206,640 men diagnosed with the condition during 2009. The number of men being actively treated for prostrate disorders such as benign…
